Fitzgerald Kevin Joseph sold ALNY
October 2, 2025 · Form 4 insider transaction
Fitzgerald Kevin Joseph sold 3 shares of Alnylam Pharmaceuticals, Inc. at $457.64 per share, a transaction worth $1.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
3
Price
$457.64
Total value
$1.4K
InsiderFitzgerald Kevin Joseph
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 2, 2025
Filing dateOctober 3, 2025
Shares owned after25,231
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares automatically sold by the Company on behalf of the reporting person pursuant to a mandatory sell-to-cover provision in the award agreement required to cover minimum statutory tax withholding obligations that became due upon the vesting and settlement of tranches of PSUs granted to the reporting person on February 24, 2021 and March 1, 2024.